SignalChem Diagnostics

SignalChem Diagnostics, established in 2018, is a subsidiary of SignalChem Lifesciences, based in Richmond, British Columbia, Canada. The company emerged from the growing demand for precise raw materials for diagnostic applications. Building on its parent company’s strengths in protein expression and purification, SignalChem Diagnostics specializes in producing essential materials for molecular, immunological, and clinical diagnostics. These include reagents, enzymes, and CRISPR-associated proteins.

The company’s product portfolio includes a wide range of diagnostic tools, from immunodiagnostics to molecular diagnostics, and is particularly noted for its offerings in CRISPR-based diagnostics. Their molecular diagnostics range spans enzymes for PCR, qPCR, and isothermal amplification, while immunodiagnostics products include antibodies and allergen reagents for assays like ELISA and lateral flow tests. They also provide specific solutions for COVID-19, such as proteins and antibodies tailored to the pandemic's diagnostic needs.

SignalChem Diagnostics places a strong emphasis on product quality. Every reagent and diagnostic tool is subject to rigorous testing for activity and reproducibility to ensure reliability. This includes consistency across product lots and high purity levels.

Search for products by SignalChem Diagnostics

SignalChem Diagnostics products by Product Category

• 
  Antibodies
• 
  ELISA & Immunoassays
• 
  Inhibitors & Compound Libraries
• 
  Instruments & Equipment
• 
  Other Assays & Kits
• 
  Peptides & Proteins
• 
  Reagents & Chemicals
• 
  All Products